Mantis biotech builds a unified biomedical device testing and regulatory platform
Mantis biotech has raised $275K in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Mantis biotech is headquartered in San Francisco, United States.
Mantis biotech builds a unified biomedical device testing and regulatory platform
Mantis biotech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mantis biotech — Funding & Investors." VCBacked, December 19, 2025, https://www.vcbacked.co/company/mantis-biotech. Accessed September 15, 2026.
VCBacked. (2025). Mantis biotech — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/mantis-biotech
{{cite web |title=Mantis biotech — Funding & Investors |url=https://www.vcbacked.co/company/mantis-biotech |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated